Investor Relations

2012 Press Releases

Webcast ImageWebcast
Q1 2017 Lantheus Holdings, Inc. Earnings Conference Call  (Live)
05/02/17 at 4:30 p.m. ET
Q1 2017 Lantheus Holdings, Inc. Earnings Conference Call
Tuesday, May 2, 2017 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012
DateTitle 
11/07/12Lantheus Medical Imaging to Host Third Quarter 2012 Conference Call on November 13, 2012 at 4:00 p.m. Eastern Time
N. Billerica, Mass., November 7, 2012 – Lantheus Medical Imaging, Inc. (“Lantheus”) today announced that it will host a conference call at 4:00 p.m. ET on Tuesday, November 13, 2012 to discuss its financial and operating results for the third quarter of 2012. To access the live conference call via telephone, please dial 1-866-770-7125 (U.S. callers) or 1-617-213-8066 (international callers) and provide passcode 16600452. A live audio webcast of the call also will be available on the homepage of... 
10/31/12Lantheus Medical Imaging Extends Contract with NTP Radioisotopes to Ensure Robust Supply of LEU-Produced Molybdenum-99
Agreement Demonstrates Company’s Long-Term Commitment to Eliminate Use of HEU-produced Products No. BILLERICA, Mass. (October  31, 2012) – Lantheus Medical Imaging, Inc. (Lantheus or the Company) and two world leaders in producing medical isotopes have agreed to work together to help ensure supplies of potentially life-saving nuclear medicine using molybdenum-99 (Mo-99) sourced from Low Enriched Uranium (LEU). Lantheus, a global leader in developing, manufacturing and distributing inno... 
10/22/12Lantheus Medical Imaging and Nordion Extend Molybdenum-99 Supply Contract through 2015
No. BILLERICA, Mass. (October 22, 2012) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite® (Technetium Tc 99m Generator) generators. Mo-99 is the parent isotope of technetium-99m (Tc-99m), the medical radioisotope most widely used in nuclear medicine diagnostic imaging tests.   ... 
09/13/12Lantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 20, 2012
N. Billerica, Mass., September 13, 2012 – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that Don Kiepert, President and Chief Executive Officer, will present at the Imperial Capital Global Opportunities Conference in New York City.  The presentation will take place on Thursday, September 20, 2012, at 9:00 a.m., Eastern Time.  Mr. Kiepert will provide an overview of the Company, the sta... 
09/10/12Lantheus MI Holdings, Inc. Appoints Brian A. Markison to its Board of Directors
No. BILLERICA, Mass. (September 10, 2012) – Lantheus MI Holdings, Inc., parent company of Lantheus Medical Imaging, Inc. (the “Company”), a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced the appointment of Brian A. Markison as a member of its Board of Directors.   Mr. Markison is a seasoned executive with more than 30 years of operational, marketing, commercial development and sales experience with international pharmaceu... 
08/10/12Lantheus Medical Imaging to Host Second Quarter 2012 Conference Call on August 16, 2012 at 4:00 p.m. Eastern Time
N. Billerica, Mass., August 10, 2012 – Lantheus Medical Imaging, Inc. (“Lantheus”) today announced that it will host a conference call at 4:00 p.m. ET on Thursday, August 16, 2012 to discuss its financial and operating results for the second quarter of 2012. To access the live conference call via telephone, please dial 1-866-713-8567 (U.S. callers) or 1-617-597-5326 (international callers) and provide passcode 85064915. A live audio webcast of the call also will be available on the homepage of ... 
07/18/12Lantheus Medical Imaging Announces Appointment of Michael W. Heslop as Vice President, International
No. BILLERICA, Mass. (July 18, 2012) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced the appointment of Michael W. Heslop to the position of Vice President, International. “Mike brings extensive pharmaceutical and biotechnology industry experience and a successful track record with global business and marketing strategy development,” said Don Kiepert, President and CEO, Lantheus Medical Imagin... 
07/02/12CaRES Study Published in the Journal of the American Society of Echocardiography Further Demonstrates the Safety and Tolerability of Ultrasound Contrast Agent DEFINITY® in a Large and Diverse Patient Population
Study Evaluated More Than 1,000 Patients with Wide-ranging Characteristics, Including Pre-existing Cardiopulmonary Conditions and Critical Illness, in a Routine Clinical Setting No. BILLERICA, Mass. (July 2, 2012) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced the publication of the results from the CaRES multicenter safety registry for its ultrasound imaging agent DEFINITY® Vial for (Perf... 
06/19/12Lantheus Selected to Receive $300,000 Massachusetts-Israel Innovation Partnership Grant
Award Will Support Potential R&D Collaboration with Israel-based Check-Cap to Develop and Manufacture New 3-D Imaging Capsule for Colorectal Cancer Screening No. BILLERICA, Mass. (June 19, 2012) –Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced the company has been selected to receive a $300,000 Massachusetts-Israel Innovation Partnership (MIIP) grant. MIIP is a formal collaboration betwee... 
06/12/12Lantheus Medical Imaging to Present at Wells Fargo Securities 2012 Healthcare Conference
N. Billerica, Mass., June 12, 2012 – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that Don Kiepert, President and Chief Executive Officer, will present at the Wells Fargo Securities 2012 Healthcare Conference in Boston.  The presentation will take place on Tuesday, June 19, 2012, at 1:00 p.m., Eastern Time.  Mr. Kiepert will provide an overview of the Company, its products and its cli... 
05/31/12Lantheus Medical Imaging to Present at Jefferies 2012 Global Healthcare Conference
N. Billerica, Mass., May 31, 2012 – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that Don Kiepert, President and Chief Executive Officer, will present at the Jefferies 2012 Global Healthcare Conference on Wednesday, June 6, 2012, at 2:30 p.m., Eastern Time.  Mr. Kiepert will provide an overview of the Company, its products and its clinical development pipeline. To access a live webcast o... 
05/17/12Lantheus Medical Imaging to Host First Quarter 2012 Conference Call on May 23, 2012 at 4:00 p.m. Eastern Time
p>N. Billerica, Mass., May 17, 2012 – Lantheus Medical Imaging, Inc. (“Lantheus”) today announced that it will host a conference call at 4:00 p.m. ET on Wednesday, May 23, 2012, to discuss its financial and operating results for the first quarter of 2012. To access the live conference call via telephone, please dial 1-800-299-6183 (U.S. callers) or 1‑617-801-9713 (international callers) and provide passcode 38986556. A live audio webcast of the call also will be available on the homepage o... 
05/17/12Lantheus Appoints New Member to its Board of Directors
Addition of Samuel R. Leno Further Enhances Board’s Financial Expertise No. BILLERICA, Mass. (May 17, 2012) – Lantheus MI Holdings, Inc., parent company of Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced the appointment of Samuel R. Leno as a member of its Board of Directors.   Mr. Leno, who will also serve as the Chairman of the Audit Committee of the Board, is a strategic executive ... 
05/09/12Lantheus Medical Imaging Announces Manufacturing and Supply Agreements with Jubilant HollisterStier LLC for Cardiolite® and Neurolite®
Contracts Advance Company’s Long-term Strategy to Diversify Supply Chain and Secure Future Inventory No. BILLERICA, Mass. (May 9, 2012) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced new manufacturing and supply agreements with Jubilant HollisterStier LLC (JHS). Under separate agreements, JHS will manufacture Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injectio... 
05/03/12Lantheus Medical Imaging Announces Appointment of Alexander E. Kuta, Ph.D., as Vice President, Global Regulatory Affairs and Nigel Williams as Vice President, Quality
No. BILLERICA, Mass. (May 3, 2012) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced the hiring of two new vice presidents to further strengthen the Company’s regulatory and quality leadership. Alexander (Alex) E. Kuta, Ph.D., joins Lantheus as Vice President, Global Regulatory Affairs, and Nigel Williams is appointed to the newly created position of Vice President, Quality. “Both Alex and Nige... 
03/29/12Lantheus Medical Imaging to Host Fourth Quarter/2011 Conference Call on April 5, 2012 at 4:00 p.m. Eastern Time
N. Billerica, Mass., March 29, 2012 – Lantheus Medical Imaging, Inc. (“Lantheus”) today announced that it will host a conference call at 4:00 p.m. ET on Thursday, April 5, 2012, to discuss its financial and operating results for the fourth quarter and full year of 2011. To access the live conference call via telephone, please dial 1-866-578-5771 (U.S. callers) or 1‑617-213-8055 (international callers) and provide passcode 74253749. A live audio webcast of the call also will be available on th... 
02/23/12Lantheus Medical Imaging Announces Strategic Relationship with Beijing Double-Crane Pharmaceuticals for the Distribution and Supply of DEFINITY® in China
Demonstrates Advancement of Company’s International Expansion Strategy in Key Global Markets No. BILLERICA, Mass. (February 23, 2012) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced a strategic distribution arrangement for DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension in the People’s Republic of China, including Hong Kong S.A.R. and Macau S.A.R.  The Boa... 
02/21/12Lantheus Medical Imaging to Present at Upcoming Investor Conferences
N. Billerica, Mass., February 21, 2012 – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that the Company will be participating in the following investor conferences: Citi 2012 Global Health Care Conference Monday, February 27 at 3:30 p.m. EST 2012 RBC Capital Markets’ Healthcare Conference Tuesday, February 28 at 8:00 a.m. EST Don Kiepert, President and Chief Executive Officer, will prese... 
01/04/12Lantheus Medical Imaging Announces Chief Financial Officer Robert Gaffey to Retire
JEFFREY YOUNG APPOINTED TO SUCCEED GAFFEY AS CFO No. BILLERICA, Mass. (January 4, 2012) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that Robert Gaffey, Chief Financial Officer, will retire from the Company after more than 37 years of service to the organization, effective January 3, 2012. Jeffrey Young, CPA, has been appointed to succeed Mr. Gaffey as Chief Financial Officer, effective ...